{"id":2904,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2004-05-28","marketCap":20329.9,"name":"Alnylam Pharmaceuticals Inc","phone":"16175518200","outstanding":125.49,"symbol":"ALNY","website":"https://www.alnylam.com/","industry":"Biotechnology"},"price":148.55576,"year":2024,"month":2,"day":16,"weekday":"Friday","title":"The Potential Impact of Technology Disruptions on Alnylam Pharmaceuticals Inc and Traditional Industries","date":"2024-02-16","url":"/posts/2024/02/16/ALNY","content":[{"section":"Introduction","text":"Technological disruptions have the potential to greatly impact both Alnylam Pharmaceuticals Inc and traditional industries. These disruptions can lead to shifts in market dynamics, changes in consumer behavior, and advancements in research and development."},{"section":"Impact on Alnylam Pharmaceuticals Inc","text":"As a pharmaceutical company, Alnylam Pharmaceuticals Inc could be affected by technology disruptions in several ways. First, the development of new technologies, such as gene editing and personalized medicine, can revolutionize the treatment options available to patients. Alnylam Pharmaceuticals Inc would need to adapt and incorporate these technologies into their research and development process to remain competitive."},{"section":"Impact on Traditional Industries","text":"The impact of technological disruptions on traditional industries can vary depending on the sector. For example, advancements in automation and artificial intelligence can lead to job displacements and efficiency improvements in manufacturing industries. On the other hand, traditional retail industries may face challenges as e-commerce platforms and digital marketplaces gain popularity."},{"section":"Impact on Stocks within Traditional Industries","text":"The stocks within traditional industries may experience both positive and negative impacts from technology disruptions. Companies that successfully adapt and leverage emerging technologies may see significant growth and increased stock value. On the other hand, companies that fail to adapt or face stiff competition from technology-driven disruptors may experience declines in their stocks."},{"section":"Market Dynamics and Investor Sentiment","text":"Technology disruptions can also affect market dynamics and investor sentiment towards traditional industries and their stocks. Investors may flock to companies that embrace technological advancements and demonstrate innovation, leading to increased demand for their stocks. Conversely, traditional companies that resist or are slow to adopt new technologies may face skepticism from investors and a decline in stock prices."},{"section":"Regulatory Challenges","text":"Technology disruptions can also pose regulatory challenges for traditional industries. New technologies often outpace existing regulations, requiring regulatory bodies to adapt and establish frameworks to ensure consumer protection and industry standards. Regulatory uncertainty can impact investor confidence and hinder the growth potential of certain traditional industries."},{"section":"Conclusion","text":"In conclusion, technology disruptions can have a profound impact on Alnylam Pharmaceuticals Inc, traditional industries, and the stocks within them. It is crucial for companies and investors to stay informed about emerging technologies, adapt to changing market dynamics, and embrace innovation to navigate the challenges and seize opportunities presented by technological disruptions."},{"section":"References","text":"1. Alnylam Pharmaceuticals Inc. (2021). Homepage. Retrieved from [website]."}],"tags":["OverSold","Long","Biotechnology"],"news":[{"category":"company","date":1708018742,"headline":"Why Alnylam Pharmaceuticals Stock Is Sinking Today","id":125907638,"image":"https://g.foolcdn.com/editorial/images/765488/scientist-looking-through-microscope.jpg","symbol":"ALNY","publisher":"Yahoo","summary":"Alnylam's change to a key clinical trial design appears to have worried investors more than a small Q4 revenue miss.","url":"https://www.fool.com/investing/2024/02/15/why-alnylam-pharmaceuticals-stock-is-sinking-today/?source=eptyholnk0000202\u0026amp;utm_source=yahoo-host-full\u0026amp;utm_medium=feed\u0026amp;utm_campaign=article\u0026amp;.tsrc=rss"},{"category":"company","date":1708011004,"headline":"Alnylam (ALNY) Reports Q4 Earnings: What Key Metrics Have to Say","id":125907639,"image":"https://media.zenfs.com/en/zacks.com/5ecaf2a9bf082a5f3a554e6526b34be0","symbol":"ALNY","publisher":"Yahoo","summary":"While the top- and bottom-line numbers for Alnylam (ALNY) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.","url":"https://finance.yahoo.com/news/alnylam-alny-reports-q4-earnings-153004457.html"},{"category":"company","date":1708004263,"headline":"Alnylam Pharmaceuticals Inc (ALNY) Reports Strong Growth in 2023, Aiming for Continued Success ...","id":125907640,"image":"https://s.yimg.com/ny/api/res/1.2/0vLMDNz.YYGocNTnmobbKw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD01Mzg-/https://media.zenfs.com/en/us.finance.gurufocus/d0ac937f8bae9aa1d569dcfdc91b31a2","symbol":"ALNY","publisher":"Yahoo","summary":"Robust Revenue Growth and Pipeline Advancements Position Alnylam for Future Milestones","url":"https://finance.yahoo.com/news/alnylam-pharmaceuticals-inc-alny-reports-133743053.html"},{"category":"company","date":1708003012,"headline":"Alnylam Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentation","id":125897132,"image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","symbol":"ALNY","publisher":"SeekingAlpha","summary":"The following slide deck was published by Alnylam Pharmaceuticals, Inc.","url":"https://seekingalpha.com/article/4670649-alnylam-pharmaceuticals-inc-2023-q4-results-earnings-call-presentation"},{"category":"company","date":1708002966,"headline":"Alnylam Pharmaceuticals, Inc. (ALNY) Q4 2023 Earnings Call Transcript","id":125897134,"image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","symbol":"ALNY","publisher":"SeekingAlpha","summary":"Alnylam Pharmaceuticals, Inc. (NASDAQ:NASDAQ:ALNY) Q4 2023 Earnings Conference Call February 15, 2024 8:30 AM ETCompany ParticipantsChristine Lindenboom -...","url":"https://seekingalpha.com/article/4670646-alnylam-pharmaceuticals-inc-alny-q4-2023-earnings-call-transcript"},{"category":"company","date":1708002000,"headline":"Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Period Activity","id":125907641,"image":"https://s.yimg.com/ny/api/res/1.2/JGe.FQVZ4wnH3TMCdDluDw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD0zNDA-/https://media.zenfs.com/en/business-wire.com/c3427aa762da95b8cb0532f999e3a0c6","symbol":"ALNY","publisher":"Yahoo","summary":"CAMBRIDGE, Mass., February 15, 2024--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the fourth quarter and full year ended December 31, 2023 and reviewed recent business highlights.","url":"https://finance.yahoo.com/news/alnylam-pharmaceuticals-reports-fourth-quarter-130000144.html"},{"category":"company","date":1708000260,"headline":"Analysts Are Bullish on These Healthcare Stocks: Annovis Bio (ANVS), Alnylam Pharma (ALNY)","id":125905263,"image":"","symbol":"ALNY","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3351797486"},{"category":"company","date":1707998040,"headline":"Alnylam changes to heart drug trial spark doubts, sinking shares","id":125907642,"image":"https://www.biopharmadive.com/imgproxy/_2U-Hi41WiNJ9eQ5INoYSuY8cUh-udzSttBZQ_7bM78/g:ce/rs:fill:770:435:0/bG9jYWw6Ly8vZGl2ZWltYWdlL0dldHR5SW1hZ2VzLTkzMDUxMjM1MC5qcGc.webp","symbol":"ALNY","publisher":"Yahoo","summary":"Analysts pressed Alnylam executives on the reasons for changes to HELIOS-B, a Phase 3 study in ATTR amyloidosis with cardiomyopathy that is important to the company’s future.","url":"https://www.biopharmadive.com/news/alnylam-helios-b-trial-change-delay-vutrisiran/707641/"},{"category":"company","date":1707985269,"headline":"Alnylam: Q4 Earnings Snapshot","id":125893378,"image":"","symbol":"ALNY","publisher":"Finnhub","summary":"CAMBRIDGE, Mass. — CAMBRIDGE, Mass. — Alnylam Pharmaceuticals Inc. on Thursday reported a loss of $137.9 million in its fourth quarter. On a per-share basis, the Cambridge,...","url":"https://finnhub.io/api/news?id=219c1e3e9ca8c72a9c6cb498c19a9bb993d168decf72c5617a8f6dc06463721a"},{"category":"company","date":1707985140,"headline":"Alnylam posts Q4 topline miss; pushes back key data readout","id":125895057,"image":"","symbol":"ALNY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3351399021"},{"category":"company","date":1707980940,"headline":"Alnylam reports Q4 EPS (77c), consensus ($1.32)","id":125905270,"image":"","symbol":"ALNY","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3351303320"},{"category":"company","date":1707980880,"headline":"Alnylam Pharmaceuticals Non-GAAP EPS of -$0.77 in-line, revenue of $439.72M misses by $2.58M","id":125905271,"image":"","symbol":"ALNY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3351301649"},{"category":"company","date":1707974760,"headline":"Alnylam Pharma (ALNY) was downgraded to a Hold Rating at Goldman Sachs","id":125905272,"image":"","symbol":"ALNY","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3352331879"},{"category":"company","date":1707974520,"headline":"Alnylam just downgraded at Goldman Sachs, here's why","id":125905273,"image":"","symbol":"ALNY","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3352324857"},{"category":"company","date":1707970980,"headline":"Earnings Scheduled For February 15, 2024","id":125894084,"image":"","symbol":"ALNY","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3351135244"},{"category":"company","date":1707923520,"headline":"Drug, Biotech Stock Q4 Earnings Due on Feb 15: ALNY, BPMC \u0026 More","id":125862498,"image":"https://media.zenfs.com/en/zacks.com/e10425bef32c421f16ccc0d2a8c8bb61","symbol":"ALNY","publisher":"Yahoo","summary":"Let's look at five biotech/drug companies, ALNY, BPMC, AGIO, CORT and RARE, slated to release quarterly results on Feb 15.","url":"https://finance.yahoo.com/news/drug-biotech-stock-q4-earnings-151200603.html"},{"category":"company","date":1707904680,"headline":"Alnylam Pharmaceuticals Q4 2023 Earnings Preview","id":125888326,"image":"","symbol":"ALNY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3349496450"},{"category":"company","date":1707891300,"headline":"Alnylam initiated with neutral view at Wolfe Research, here's why","id":125888329,"image":"","symbol":"ALNY","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3350334943"},{"category":"company","date":1707880680,"headline":"Alnylam initiated with neutral view at Wolfe Research","id":125888330,"image":"","symbol":"ALNY","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3350002715"},{"category":"company","date":1707876540,"headline":"Alnylam Pharmaceuticals's Earnings Outlook","id":125888332,"image":"","symbol":"ALNY","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3349889083"},{"category":"company","date":1707836436,"headline":"CRISPR Therapeutics AG (CRSP) May Report Negative Earnings: Know the Trend Ahead of Q4 Release","id":125835063,"image":"https://media.zenfs.com/en/zacks.com/7853de8d69faeccb7d1ad6ebba40b8a2","symbol":"ALNY","publisher":"Yahoo","summary":"CRISPR Therapeutics AG (CRSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.","url":"https://finance.yahoo.com/news/crispr-therapeutics-ag-crsp-may-150036883.html"},{"category":"company","date":1707808800,"headline":"Alnylam price target lowered by $8 at Morgan Stanley, here's why","id":125852791,"image":"","symbol":"ALNY","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3347391111"},{"category":"company","date":1707747366,"headline":"Gear Up for Alnylam (ALNY) Q4 Earnings: Wall Street Estimates for Key Metrics","id":125801834,"image":"https://media.zenfs.com/en/zacks.com/078b2d95159d12a337f09f2519ff10ba","symbol":"ALNY","publisher":"Yahoo","summary":"Beyond analysts' top -and-bottom-line estimates for Alnylam (ALNY), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.","url":"https://finance.yahoo.com/news/gear-alnylam-alny-q4-earnings-141606324.html"},{"category":"company","date":1707723180,"headline":"Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Waters (WAT) and Biohaven Ltd. (BHVN)","id":125800144,"image":"","symbol":"ALNY","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3345648457"},{"category":"company","date":1707717960,"headline":"RBC Capital Remains a Buy on Alnylam Pharma (ALNY)","id":125803699,"image":"","symbol":"ALNY","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3345562874"},{"category":"company","date":1707404449,"headline":"Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Can the Stock Move Higher?","id":125665465,"image":"https://media.zenfs.com/en/zacks.com/71afbbc0512eb3c471136d93f39079c9","symbol":"ALNY","publisher":"Yahoo","summary":"Alnylam (ALNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.","url":"https://finance.yahoo.com/news/alnylam-pharmaceuticals-alny-expected-beat-150049518.html"},{"category":"company","date":1707374760,"headline":"Positive Outlook for Alnylam Pharma: Buy Rating Backed by Strong HELIOS-B Trial Prospects","id":125647957,"image":"","symbol":"ALNY","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3339501742"},{"category":"company","date":1707222780,"headline":"(ALNY) - Analyzing Alnylam Pharmaceuticals's Short Interest","id":125616876,"image":"","symbol":"ALNY","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3335924748"},{"category":"company","date":1707170529,"headline":"Insider Sell: EVP, CLO \u0026 Secretary Indrani Franchini Sells 1,591 Shares of Alnylam ...","id":125544632,"image":"https://media.zenfs.com/en/us.finance.gurufocus/12badfd282e91dbed20f518d875c4c77","symbol":"ALNY","publisher":"Yahoo","summary":"Alnylam Pharmaceuticals Inc (NASDAQ:ALNY), a biopharmaceutical company, focuses on the discovery, development, and commercialization of RNA interference (RNAi) therapeutics.","url":"https://finance.yahoo.com/news/insider-sell-evp-clo-secretary-220209904.html"},{"category":"company","date":1707141600,"headline":"Rare Stock Picks In January 2024 - From 45 Discerning Analysts","id":125536262,"image":"https://static.seekingalpha.com/uploads/2024/2/5/saupload_needle_in_haystack.png","symbol":"ALNY","publisher":"SeekingAlpha","summary":"In our monthly Rare Stock Picks series, we're highlighting January 2024 investment picks. Click here for the list of January 2024 Buy recommendations.","url":"https://seekingalpha.com/article/4667578-rare-stock-picks-in-january-2024-from-45-discerning-analysts"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc R\u0026D Day Transcript","id":125617025,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665495"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc at Piper Sandler Healthcare Conference Transcript","id":125617024,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665496"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc at Stifel Healthcare Conference Transcript","id":125617022,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665497"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc at Jefferies London Healthcare Conference Transcript","id":125617021,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665498"},{"category":"company","date":1707117420,"headline":"Q3 2023 Alnylam Pharmaceuticals Inc Earnings Call Transcript","id":125617018,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665499"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc To Host Investor Call Transcript","id":125617015,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665500"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc at Canaccord Genuity Growth Conference Transcript","id":125617011,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665501"},{"category":"company","date":1707117420,"headline":"Q2 2023 Alnylam Pharmaceuticals Inc Earnings Call Transcript","id":125617010,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665502"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc to Discuss Collaboration with Roche Transcript","id":125617005,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665503"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc at Goldman Sachs Healthcare Conference Transcript","id":125617001,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665504"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc at Bank of America Global Healthcare Conference Transcript","id":125616997,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665505"},{"category":"company","date":1707117420,"headline":"Q1 2023 Alnylam Pharmaceuticals Inc Earnings Call Transcript","id":125616993,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665506"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc ALN-APP Call Transcript","id":125616989,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665507"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc at Ginkgo Bioworks Ferment Conference Transcript","id":125616985,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665508"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc at Stifel CNS Days (Virtual) Transcript","id":125616982,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665509"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript","id":125616977,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665510"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc at Oppenheimer Healthcare Conference (Virtual) Transcript","id":125616973,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665511"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc at Cowen Health Care Conference Transcript","id":125616970,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665512"},{"category":"company","date":1707117420,"headline":"Q4 2022 Alnylam Pharmaceuticals Inc Earnings Call Transcript","id":125616968,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665513"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript","id":125616963,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665514"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc at Evercore ISI HealthCONx Conference (Virtual) Transcript","id":125616950,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665517"},{"category":"company","date":1707117420,"headline":"","id":125616940,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665520"},{"category":"company","date":1707117420,"headline":"Q3 2022 Alnylam Pharmaceuticals Inc Earnings Call Transcript","id":125616936,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665521"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc to Discuss APOLLO-B Results at HFSA Scientific Meeting Transcript","id":125616927,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665523"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference Transcript","id":125616920,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665525"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc to Discuss APOLLO-B Results - Conference Call Transcript","id":125616917,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665526"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc to Discuss APOLLO-B Topline Results Transcript","id":125616915,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665527"},{"category":"company","date":1707117420,"headline":"Q2 2022 Alnylam Pharmaceuticals Inc Earnings Call Transcript","id":125616912,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665528"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc to Discuss FDA Approval of AMVUTTRA (Vutrisiran) Transcript","id":125616911,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665529"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc at Goldman Sachs Global Healthcare Conference Transcript","id":125616908,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665530"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript","id":125616905,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665531"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc at UBS Global Healthcare Conference Transcript","id":125616903,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665532"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc at H C Wainwright Global Investment Conference (Virtual) Transcript","id":125616899,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665533"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc at Bank of America Healthcare Conference Transcript","id":125616895,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665534"},{"category":"company","date":1707117420,"headline":"Q1 2022 Alnylam Pharmaceuticals Inc Earnings Call Transcript","id":125616893,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665535"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc at Cowen Health Care Conference (Virtual) Transcript","id":125616887,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665538"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc at SVB Leerink Global Healthcare (Virtual) Transcript","id":125616885,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665539"},{"category":"company","date":1707117420,"headline":"Q4 2021 Alnylam Pharmaceuticals Inc Earnings Call Transcript","id":125616883,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665540"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc to Present HELIOS-A 18-Month Results - Conference Call Transcript","id":125616882,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665541"},{"category":"company","date":1707117420,"headline":"Alnylam Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript","id":125616880,"image":"","symbol":"ALNY","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3334665542"},{"category":"company","date":1707020400,"headline":"Investors growing more bullish on SMID cap biotech stocks","id":125516582,"image":"","symbol":"ALNY","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3333024848"},{"category":"company","date":1706877830,"headline":"Regeneron's Push Into Obesity, Q4 2023 Earnings Review","id":125484799,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1452594824/image_1452594824.jpg?io=getty-c-w1536","symbol":"ALNY","publisher":"SeekingAlpha","summary":"Return to growth and improving growth prospects should translate to continued share price gains for Regeneron. Find out if REGN stock is a buy.","url":"https://seekingalpha.com/article/4667130-regenerons-push-into-obesity-q4-2023-earnings-review"},{"category":"company","date":1706860380,"headline":"Chardan lays out top 4 biotech picks for 2024","id":125484353,"image":"","symbol":"ALNY","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3330050778"}]}